Under the terms of the agreement, Tessella and Cmed will ensure interoperability of Timaeus, the intelligent data acquisition and management system with Tessella Fates, Tessella’s fixed and adaptive trial execution system.
Tom Parke, head of clinical technologies at Tessella, said: “With Timaeus, organizations have the ability to acquire, manage and report data in near real-time. This is particularly important for adaptive trials because it minimizes the delay in the availability of response data and therefore adaptation of the trial.
“The interoperability of two best of breed clinical trial products represents an important step in removing the operational complexity associated with adaptive clinical trials.”